Literature DB >> 6822234

Decreased phenytoin level during antineoplastic therapy: a case report.

P Bollini, R Riva, F Albani, N Ida, L Cacciari, C Bollini, A Baruzzi.   

Abstract

We report a case of interaction between anticonvulsant and antineoplastic drugs in one male patient with seizures from brain tumour. The patient was treated with phenytoin (PHT), phenobarbital (PB), and an antineoplastic protocol based on a combination regimen with carmustine (BCNU), vinblastin (VLB), methotrexate (MTX), and radiotherapy. Plasma concentrations of PHT fell from 9.4 to 5.6 micrograms/ml 24 h after VLB administration, and remained low for at least 10 days. During this period, partial seizures occurred. Plasma concentrations of PB were unchanged during the period of observation. It is suggested that impaired absorption of PHT, caused by VLB or MTX or both, is responsible for this interaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822234     DOI: 10.1111/j.1528-1157.1983.tb04868.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  Seizure prophylaxis and melanoma brain metastases.

Authors:  S A Goldlust; M Hsu; A B Lassman; K S Panageas; E K Avila
Journal:  J Neurooncol       Date:  2012-02-05       Impact factor: 4.130

Review 2.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 3.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 4.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 5.  Epilepsy in the elderly.

Authors:  Ilo E Leppik; Angela K Birnbaum
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient.

Authors:  Hiroaki Ikeda; Teruo Murakami; Mikihisa Takano; Tsuguru Usui; Kenji Kihira
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

7.  A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.

Authors:  Adam S Wu; Victoria T Trinh; Dima Suki; Susan Graham; Arthur Forman; Jeffrey S Weinberg; Ian E McCutcheon; Sujit S Prabhu; Amy B Heimberger; Raymond Sawaya; Xuemei Wang; Wei Qiao; Kenneth Hess; Frederick F Lang
Journal:  J Neurosurg       Date:  2013-02-08       Impact factor: 5.115

8.  Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

Authors:  M Hassan; G Oberg; M Björkholm; I Wallin; M Lindgren
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.

Authors:  C Ghosh; H M Lazarus; J S Hewlett; R J Creger
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.